The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis (Q39523831)

12 September 2017

The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis (English)

1 reference

12 September 2017

1 reference

James Leiper

12

0 references

Soni Savai Pullamsetti

Soni Savai Pullamsetti

1

0 references

Norbert Weissmann

Norbert Weissmann

9

0 references

Ralph T Schermuly

Ralph Theo Schermuly

15

0 references

Werner Seeger

Werner Seeger

13

0 references

Oliver Eickelberg

10

Oliver Eickelberg

1 reference

12 September 2017

14

Friedrich Grimminger

1 reference

12 September 2017

11

Andreas Guenther

1 reference

12 September 2017

3

Rio Dumitrascu

1 reference

12 September 2017

8

Hossein Ardeschir Ghofrani

1 reference

12 September 2017

5

Jochen Wilhelm

1 reference

12 September 2017

2

Rajkumar Savai

1 reference

12 September 2017

6

Melanie Konigshoff

1 reference

12 September 2017

4

Bhola Kumar Dahal

1 reference

12 September 2017

7

Dariusz Zakrzewicz

1 reference

PubMed ID

21677199

12 September 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

Science Translational Medicine

12 September 2017

1 reference

12 September 2017

3

1 reference

12 September 2017

87

1 reference

12 September 2017

87ra53

1 reference

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

12 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Mechanisms of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Expression of nitric oxide synthase, aquaporin 1 and aquaporin 5 in rat after bleomycin inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

State of the arg: protein methylation at arginine comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Disruption of methylarginine metabolism impairs vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

The p53 pathway: positive and negative feedback loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Demystifying idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

ADMA: an emerging cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Molecular mechanisms of endothelial dysfunction: from nitric oxide synthesis to ADMA inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Nitric oxide and wound repair: role of cytokines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Emerging drugs for diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Antifibrotic role of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

The ultrastructure of human fibrosing alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Increased eNO and pulmonary iNOS expression in eNOS null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Simple method of estimating severity of pulmonary fibrosis on a numerical scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001725

10.1126/SCITRANSLMED.3001725

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

21677199